ARCHIVES

ODAC Recommends Femara Campath For FDA Approval.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: ACCC Honors Henry Lynch; Gunderson Names Chair, Mayo Oncology Department

October 11, 1996

NIH Funding Strategies, UICC Fellowships

December 4, 1992

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014

ACCC Comments On DRGs to Be Review By PROPAC

September 6, 1985

NCI Cooperative Group, Cancer Center Trials Listed

July 25, 2008

ASCO Letter To NCI Urges Increased Support for Clinical Trials, Training, Translational Research

March 6, 2009